Online inquiry

IVTScrip™ mRNA-Human ANKMY1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK21494MR)

This product GTTS-WK21494MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKMY1 protein. This product can be used in Ciliated epithelial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001282771.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51281
UniProt ID Q9P2S6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKMY1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK21494MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK8935MR IVTScrip™ mRNA-Human ADGRD2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRD2
GTTS-WK27987MR IVTScrip™ mRNA-Human ARHGAP21, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARHGAP21
GTTS-WK28326MR IVTScrip™ mRNA-Human ARID4B, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARID4B
GTTS-WK12567MR IVTScrip™ mRNA-Human ADRA2A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADRA2A
GTTS-WK14330MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK20429MR IVTScrip™ mRNA-Human AIDA, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AIDA
GTTS-WK22600MR IVTScrip™ mRNA-Human ARHGAP45, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARHGAP45
GTTS-WK10162MR IVTScrip™ mRNA-Human ADORA3, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADORA3
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW